Multicenter, randomized phase II trial of bevacizumab plus folinic acid, fluorouracil, gemcitabine (FFG) versus bevacizumab plus folinic acid, fluorouracil, oxaliplatin (FOLFOX4) as first-line therapy for patients with advanced colorectal cancer

By Madajewicz Stefan  

Investigational New Drugs, Vol. 30, Iss. 2, 2012-04 ,pp. : 772-778

Springer Publishing Company

Access to resources Recommend Favorite

Fluorouracil/folinic acid: Mucosal deterioration: case report

By  

Reactions Weekly, Vol. 1, Iss. 1237, 2009-01 ,pp. : 11-12

Adis International

Access to resources Recommend Favorite

A combination of oxaliplatin, fluorouracil and folinic acid (FOLFOX-6) appears promising for locally advanced and metastatic pancreatic cancer

By  

Inpharma, Vol. 1, Iss. 1582-1583, 2007-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Irinotecan plus fluorouracil and folinic acid should be the comparator regimen in clinical trials involving patients with metastatic colorectal cancer

By  

Inpharma, Vol. 1, Iss. 1232, 2000-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

A Cost Comparison of Oral Tegafur Plus Uracil/Folinic Acid and Parenteral Fluorouracil for Colorectal Cancer in Canada

By Maroun J.A.  

PharmacoEconomics, Vol. 21, Iss. 14, 2003-01 ,pp. : 1039-1051

Adis International

Access to resources Recommend Favorite